Treace Medical Concepts Stock Buy Hold or Sell Recommendation
| TMCI Stock | USD 7.83 0.11 1.39% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Treace Medical Concepts is 'Cautious Hold'. The recommendation algorithm takes into account all of Treace Medical's available fundamental, technical, and predictive indicators you will find on this site.
Check out Treace Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Treace and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Treace |
Execute Treace Medical Buy or Sell Advice
The Treace recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Treace Medical Concepts. Macroaxis does not own or have any residual interests in Treace Medical Concepts or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Treace Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Hold | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Treace Medical Trading Alerts and Improvement Suggestions
| Treace Medical had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 187.12 M. Net Loss for the year was (49.53 M) with profit before overhead, payroll, taxes, and interest of 114.31 M. | |
| Treace Medical Concepts currently holds about 101.53 M in cash with (34.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. | |
| Roughly 64.0% of the company shares are owned by institutional investors | |
| Latest headline from accesswire.com: Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm |
Treace Medical Returns Distribution Density
The distribution of Treace Medical's historical returns is an attempt to chart the uncertainty of Treace Medical's future price movements. The chart of the probability distribution of Treace Medical daily returns describes the distribution of returns around its average expected value. We use Treace Medical Concepts price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Treace Medical returns is essential to provide solid investment advice for Treace Medical.
| Mean Return | 0.45 | Value At Risk | -4.39 | Potential Upside | 6.08 | Standard Deviation | 5.52 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Treace Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Treace Stock Institutional Investors
| Shares | D. E. Shaw & Co Lp | 2024-06-30 | 761.2 K | Kent Lake Capital Llc | 2024-06-30 | 750 K | Millennium Management Llc | 2024-06-30 | 686 K | Kornitzer Capital Management Inc | 2024-09-30 | 526.9 K | Citadel Advisors Llc | 2024-06-30 | 491.9 K | Gagnon Advisors, Llc | 2024-09-30 | 489.9 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 463 K | Northern Trust Corp | 2024-09-30 | 458.2 K | Jpmorgan Chase & Co | 2024-06-30 | 400.5 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 5.7 M | Armistice Capital, Llc | 2024-06-30 | 5.4 M |
Treace Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Treace Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Treace Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Treace stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 4.55 | |
σ | Overall volatility | 5.57 | |
Ir | Information ratio | 0.06 |
Treace Medical Volatility Alert
Treace Medical Concepts currently demonstrates below-average downside deviation. It has Information Ratio of 0.06 and Jensen Alpha of -0.01. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Treace Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Treace Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Treace Medical Fundamentals Vs Peers
Comparing Treace Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Treace Medical's direct or indirect competition across all of the common fundamentals between Treace Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Treace Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Treace Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Treace Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Treace Medical to competition |
| Fundamentals | Treace Medical | Peer Average |
| Return On Equity | -0.51 | -0.31 |
| Return On Asset | -0.17 | -0.14 |
| Profit Margin | (0.30) % | (1.27) % |
| Operating Margin | (0.34) % | (5.51) % |
| Current Valuation | 481.96 M | 16.62 B |
| Shares Outstanding | 62.3 M | 571.82 M |
| Shares Owned By Insiders | 24.82 % | 10.09 % |
| Shares Owned By Institutions | 64.34 % | 39.21 % |
| Number Of Shares Shorted | 4.94 M | 4.71 M |
| Price To Book | 4.72 X | 9.51 X |
| Price To Sales | 2.44 X | 11.42 X |
| Revenue | 187.12 M | 9.43 B |
| Gross Profit | 114.31 M | 27.38 B |
| EBITDA | (39.01 M) | 3.9 B |
| Net Income | (49.53 M) | 570.98 M |
| Cash And Equivalents | 101.53 M | 2.7 B |
| Cash Per Share | 1.83 X | 5.01 X |
| Total Debt | 70.3 M | 5.32 B |
| Debt To Equity | 0.99 % | 48.70 % |
| Current Ratio | 8.13 X | 2.16 X |
| Book Value Per Share | 1.69 X | 1.93 K |
| Cash Flow From Operations | (34.58 M) | 971.22 M |
| Short Ratio | 12.74 X | 4.00 X |
| Earnings Per Share | (0.99) X | 3.12 X |
| Target Price | 7.5 | |
| Number Of Employees | 516 | 18.84 K |
| Beta | 0.24 | -0.15 |
| Market Capitalization | 494.64 M | 19.03 B |
| Total Asset | 251.91 M | 29.47 B |
| Retained Earnings | (134.25 M) | 9.33 B |
| Working Capital | 153.33 M | 1.48 B |
| Net Asset | 251.91 M |
Note: Acquisition by Scot Elder of 200000 shares of Treace Medical subject to Rule 16b-3 [view details]
Treace Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Treace . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 11080.98 | |||
| Daily Balance Of Power | (0.41) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 7.89 | |||
| Day Typical Price | 7.87 | |||
| Price Action Indicator | (0.11) | |||
| Period Momentum Indicator | (0.11) |
About Treace Medical Buy or Sell Advice
When is the right time to buy or sell Treace Medical Concepts? Buying financial instruments such as Treace Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Treace Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Debt ETFs Thematic Idea Now
Broad Debt ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Debt ETFs theme has 229 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Debt ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Treace Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share 3.274 | Quarterly Revenue Growth 0.106 | Return On Assets (0.17) | Return On Equity (0.51) |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.